According to analyses of Transparency International Slovakia (TIS), Ministry of Health decides which drugs will be covered by health insurance not always in accordance with applicable regulations. TIS analysis points out that half of the applications for new drugs in the past year have not been settled up within the statutory period of six months; the ministry generally lacked expert opinions, and never once was assessing the cost-effectiveness and impact on public finances, despite the fact that the law requires it. Health insurance companies paid annually on drugs 850 million euros, what represents about a third of the total cost on health care from public sources. The analysis examined the categorization of drugs for about one year.